NEW YORK, Aug.  05, 2026  (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Hims &amp; Hers Health, Inc. (&#34;Hims&#34; or the &#34;Company&#34;) (NYSE:HIMS). The

HIMS

HIMS & HERS HEALTH, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

FTC privacy lawsuit creates regulatory overhang for Hims shares

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>NEW YORK, Aug.  05, 2026  (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Hims &amp;amp; Hers Health, Inc. (&amp;#34;Hims&amp;#34; or the &amp;#34;Company&amp;#34;) (NYSE:HIMS). The</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>FTC files a lawsuit against Hims over deceptive privacy practices, including data shared with Meta. The stock dropped 14.7% to $25 on July 29, 2026, highlighting immediate regulatory risk. Kirby McInerney LLP is probing potential securities claims, suggesting litigation costs even if no class action is filed yet. Investors should watch for regulator updates, settlements, or new privacy disclosures that could move HIMS short-term.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>FTC files lawsuit against Hims for deceptive privacy practices. Stock falls 14.7% to $25 on July 29, 2026.</li><li>Kirby McInerney LLP investigating potential securities claims vs Hims; no class-action filed yet.</li><li>FTC alleges data-sharing with Meta Platforms; privacy risk to advertisers and regulatory exposure.</li><li>Regulatory/litigation overhang could pressure valuation; monitor for settlements and disclosures.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Hims &amp; Hers Health, Inc. (HIMS)</strong>: Subject of FTC privacy lawsuit; stock volatility and ongoing regulatory exposure likely.</li><li><strong>Meta Platforms, Inc. (META)</strong>: FTC complaint cites data shared with Meta; privacy concerns could affect advertising relationship.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Category: Legal. The piece centers on regulatory action and potential securities litigation against HIMS, a key driver of near-term price movement and risk assessment.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>FTC lawsuit heightens privacy-regulatory risk for HIMS and may trigger penalties.</li><li>Kirby McInerney LLP&#039;s securities-claims inquiry signals potential litigation costs.</li><li>Meta data-sharing angle underscores broader ad-tech privacy scrutiny affecting HIMS&#039; ecosystem.</li><li>Shares likely to remain volatile until regulators provide clarity or settlements emerge.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>FTC filed lawsuit against Hims on July 29, 2026.</li><li>Hims closed at $25.00 on July 29, 2026; down 14.73%.</li><li>Stock declined by $4.32 per share on July 29, 2026.</li><li>Kirby McInerney LLP announced an investigation into potential securities claims against Hims.</li><li>FTC alleges sharing patients&#039; health data with Meta Platforms.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Bearish near-term risk; volatility likely until regulatory action clarity in 1–3 quarters.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify">NEW YORK, Aug.  05, 2026  (GLOBE NEWSWIRE) -- The law firm of <a href="https://www.globenewswire.com/Tracker?data=gl7b2_2xdgdoLGdHIw8E8_DYJ8yjWryHP6az3tlVAwU72z9QSKb4sliuvcPp5BxTwjwjbhU3lCt3OSVEGReS4AC5zU9PFH9QZULcVDgrm3c=" rel="nofollow" target="_blank">Kirby McInerney LLP</a> is investigating potential claims against Hims &amp; Hers Health, Inc. ("Hims" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/HIMS">HIMS</a>). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.</p>  <p align="center">[<a href="https://www.globenewswire.com/Tracker?data=GxktVmOyhuwjfLUcnXDsG0MbJHskiIowjmpZ3obRvse5v5YHqhgV9DMWbJrq-X84ObWjTEe4Wop8FZWkLDym3FcRA0Mx5n8pGnLAot0RR6j-2BoRAS22153sikju_hkDxzZWfkivczUrdlqvo5063I896zGbaHk5raBYtEgI3uA=" rel="nofollow" target="_blank">LEARN MORE ABOUT THE INVESTIGATION</a>]</p>  <p align="justify"><strong>What Happened?</strong></p>  <p align="justify">On July 29, 2026, the Federal Trade Commission (the "FTC") filed a lawsuit against Hims, accusing the Company of sharing customers’ medical information with third-party advertisers. The FTC complaint accuses the Company of "deceptive and unlawful privacy practices," including sharing sensitive details about patients’ health with Meta Platforms. On this news, Hims’s stock price fell $4.32 per share, or 14.73%, to close at $25.00 on July 29, 2026.</p>  <p align="justify"><strong>What Should I Do?</strong></p>  <p align="justify">At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.</p>  <p align="justify">If you purchased or otherwise acquired Hims securities, have information, or would like to learn more about this investigation, please contact <a href="https://www.globenewswire.com/Tracker?data=gA5ImKFGpMKJdxEjsW6FXQgLrF4g29ocZStBV65paPZsbjxcb-N1t621Dnbq1hNJ2muXIB7ZoZcP0tdweGsfKR3a2jn7bp6uV9DbG2jKHH_uu5dgKqQRkFAU27hOOyb1" rel="nofollow" target="_blank">Lauren Molinaro</a> of <a href="https://www.globenewswire.com/Tracker?data=gl7b2_2xdgdoLGdHIw8E82oeynt-48CWjFz3uiflTSkFKF8PtfPyKz528bytZIyIhH6wyiixOJL0wjyhJoI8pkGinN2vdFp4PBjT3kvdPtk=" rel="nofollow" target="_blank">Kirby McInerney LLP</a> by email at <a href="https://www.globenewswire.com/Tracker?data=A8XC8enZZx-jc-IMJmuVaeYjCWNoU6nfVivWxfKHh8fyR_jndNxQZiFjvEOurOGkkimeSlJy9qpwkTHEEWhthL9r-6IVeUzZGfolS1unUvXKMbqvJNb8aNz29MWMUXrV" rel="nofollow" target="_blank">investigations@kmllp.com</a>, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.</p>  <p align="center">[<a href="https://www.globenewswire.com/Tracker?data=GxktVmOyhuwjfLUcnXDsG_M4FCYo5T8uB9u-hxVOqvTxHle9ZYNoE35tEfcyIUyD0X_Ksayx0wahK01KfyFF145L2fY6Xfd5ie4iPoXuVGk0q8lMFabQg_THkAG4C7A7r6zBRRKhaeK0PXFMZVSTjA==" rel="nofollow" target="_blank">LEARN MORE ABOUT SECURITIES CLASS ACTIONS</a>]</p>  <p align="justify"><a href="https://www.globenewswire.com/Tracker?data=gl7b2_2xdgdoLGdHIw8E84ythYQm6OY3g2xHDs7r1PPCFWi75ZRdaMnwec3NCjdnI_Yyp94Qe8rXhaR-gQjRiMTFnd7alNfSQYdueqx8JNY=" rel="nofollow" target="_blank">Kirby McInerney LLP</a> is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s <a href="https://www.globenewswire.com/Tracker?data=YCGw20JeItoEcB4-LV60N1is2V8blZfG-ix85dCKz9Dzv5wW_ZIdX_M0YBbBm4M4JN_6Nrgo1v_OcMZGzV0cDQ==" rel="nofollow" target="_blank">website</a>.</p>  <p align="justify">This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.</p>  <p align="justify">Contacts<br></br>Kirby McInerney LLP        <br></br>Lauren Molinaro, Esq.<br></br>212-699-1171<br></br><a href="https://www.globenewswire.com/Tracker?data=ninEkTHgBJTMVZ-aC0xsaiGseReCF2hKm7qFXU7O0OXGVXmeqmXwawMdXSR0LoHxUR87hfAqVaPQuEsfNXUmofty1NQFLPihSeAT0cHyhPo=" rel="nofollow" target="_blank">https://www.kmllp.com</a><br></br><u>https://securitiesleadplaintiff.com/</u><br></br><a href="https://www.globenewswire.com/Tracker?data=A8XC8enZZx-jc-IMJmuVaeYjCWNoU6nfVivWxfKHh8fisjIUfhKuJUONjjjyKd9EUY3HLp_iZVrU71dgHrtmPcU_kBMqidjfr5x6XBOrUpPQswjH6can0fr20j3JjYrY" rel="nofollow" target="_blank">investigations@kmllp.com</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTgwNDczMSM3NzYxOTAzIzIwMjA2Njk="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/MWI1NWQzYmEtZmMzZi00YTVhLTkzMDUtYjc1YTBjNzA5NmRjLTEwMzE5OTctMjAyNi0wOC0wNi1lbg==/tiny/Kirby-McInerney-LLP.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/192da1d1-643f-4eee-b850-dde5b9f2b00f"><img src="https://ml.globenewswire.com/media/192da1d1-643f-4eee-b850-dde5b9f2b00f/small/linkedin-logo-300x300-png.png" border="0" width="147" height="147" alt="Primary Logo"></img></a></p>

FTC files a lawsuit against Hims over deceptive privacy practices, including data shared with Meta. The stock dropped 14.7% to $25 on July 29, 2026, highlighting immediate regulatory risk. Kirby McInerney LLP is probing potential securities claims, suggesting litigation costs even if no class action is filed yet. Investors should watch for regulator updates, settlements, or new privacy disclosures that could move HIMS short-term.

News insight

HIMS & HERS HEALTH, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

AI summary

Sentiment rationale

Key facts

Legal